Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Actinic Keratosis Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Therapy (Antimetabolite Chemotherapy Agents, Immune Response Modifiers, NSAID-Based Anti-proliferative Agents, Microtubule Inhibitors), By End User (Hospitals, Dermatology Clinics, Aesthetic & Laser Centers, Ambulatory Surgical Centers ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Actinic Keratosis Drugs Market size is forecast to increase from $2.71 Billion in 2026 to $3.82 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005387
Pages: 217 Pages

Actigraphy Sensors and Polysomnography Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Actigraphy Sensors, Polysomnography ), By Technology (Wireless Technology, USB Connectivity, GPS-enabled Devices), By Distribution Channel (Hospitals & Sleep Clinics, Diagnostic Laboratories, Homecare Settings, Retail Stores & Pharmacies, Online Sales Channels) Companies, and Country Forecast, 2021 to 2034

Global Actigraphy Sensors and Polysomnography Devices Market size is forecast to increase from $2.33 Billion in 2026 to $3.66 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005386
Pages: 228 Pages

Acromegaly and Gigantism Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Somatostatin Analogs , Growth Hormone Receptor Antagonists , Dopamine Agonists, Recombinant Human IGF-1), By Disease Type (Acromegaly, Gigantism), By Route of Administration (Parenteral , Oral), By End User (Hospitals, Specialty Clinics, Pharmacy Stores, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Acromegaly and Gigantism Drugs Market size is forecast to increase from $2.19 Billion in 2026 to $3.07 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005385
Pages: 212 Pages

Acquired Orphan Blood Diseases Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Disease Indication (Acquired Hemophilia, Paroxysmal Nocturnal Hemoglobinuria , Myelodysplastic Syndrome , Acquired Agranulocytosis, Acquired von Willebrand Syndrome), By Therapy Type (Recombinant Factors, Immunoglobulin Infusion Therapy, Thrombopoietin Receptor Agonists , Activated Prothrombin Complex Concentrates , Monoclonal Antibodies & Target Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Acquired Orphan Blood Diseases Therapeutics Market size is forecast to increase from $11.07 Billion in 2026 to $19.89 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005384
Pages: 214 Pages

Acoustic Neuroma Market Size, Share and Growth Outlook, 2026: Analysis By Type (Unilateral Acoustic Neuroma, Bilateral Acoustic Neuroma), By Diagnosis (Magnetic Resonance Imaging , Computerized Tomography , Audiometry, Electrophysiology / Electronystagmography ), By Treatment (Surgery / Microsurgical Resection, Radiation Therapy , Active Monitoring / Observation , Drug Therapy / Medical Management), By Route of Administration (Oral, Parenteral), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers , Research Institutes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Acoustic Neuroma Market size is forecast to increase from $1.95 Billion in 2026 to $3.38 Billion in 2034 at a CAGR of 7.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005383
Pages: 224 Pages

Acoustic Medicine and Ultrasound Therapy Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Diagnostic Ultrasound Systems, Therapeutic Ultrasound Systems), By Modality (Bench-top Systems, Hand-held Systems, Portable / Wearable Systems), By Portability (Trolley / Cart-Based Systems, Compact / Handheld Systems), By Application (Osteoarthritis, Sports Injuries, Musculoskeletal Disorders, Emergency Medicine, Cardiovascular Applications, Oncology & Urology Surgery), By End-User (Hospitals, Private Clinics, Physiotherapy & Rehabilitation Centers) Companies, and Country Forecast, 2021 to 2034

Global Acoustic Medicine and Ultrasound Therapy Market size is forecast to increase from $2.33 Billion in 2026 to $3.66 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005382
Pages: 221 Pages

Acoustic Hailing Devices Market Size, Share and Growth Outlook, 2026: Analysis By Range (Long Range Acoustic Hailing Devices, Short and Medium Range Acoustic Hailing Devices), By Product Configuration (Fixed , Portable ), By Technology (Directional Acoustic Systems, Omnidirectional Acoustic Systems), By Application (Military and Defense, Law Enforcement and Crowd Control, Homeland and Border Security, Maritime and Port Security, Commercial Sector) Companies, and Country Forecast, 2021 to 2034

Global Acoustic Hailing Devices Market size is forecast to increase from $57.45 Million in 2026 to $183.21 Million in 2034 at a CAGR of 15.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005381
Pages: 229 Pages

Acne Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Acne Type (Inflammatory Acne, Non-Inflammatory , Cystic and Nodular Acne), By Therapeutic Class (Retinoids, Antibiotics, Hormonal Agents, Combination Drugs, Over-the-Counter ), By Mode (Topical Treatments, Oral Medications, Injectable Therapies), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Acne Drugs Market size is forecast to increase from $9.81 Billion in 2026 to $14.38 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005380
Pages: 219 Pages

ACL (Anterior Cruciate Ligament) Graft Market Size, Share and Growth Outlook, 2026: Analysis By Graft Type (Autografts, Allografts, Synthetic Grafts), By Fixation Type (Femoral Fixation, Tibial Fixation), By Type of ACL Surgery (Primary ACL Reconstruction, ACL Revision Surgery), By Patient Demographic (Pediatric , Adult , Geriatric), By Injury Type (Sports Injuries, Non-Sports Injuries), By End-User (Hospitals, Ambulatory Surgical Centers , Orthopedic Clinics) Companies, and Country Forecast, 2021 to 2034

Global ACL (Anterior Cruciate Ligament) Graft Market size is forecast to increase from $199.62 Million in 2026 to $356.02 Million in 2034 at a CAGR of 7.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005379
Pages: 230 Pages

Acinetobacter Pneumonia Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Carbapenems, Cephalosporins, Aminoglycosides, Polymyxins, Tetracyclines, Combination Therapies), By Route of Administration (Parenteral , Oral, Inhalation), By Patient Demographics (Adult, Geriatric, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Acinetobacter Pneumonia Therapeutics Market size is forecast to increase from $419.59 Million in 2026 to $678.92 Million in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005378
Pages: 221 Pages